Back to results
US 2020/0255877 A1Published application
Microbial production of nicotinamide riboside
AssigneeDsm IP Assets B.V.
InventorsAdam LAWRENCE, Celine VIAROUGE
Life of this patent
Estimating the term…
Abstract
The present invention is directed to microbial production of nicotinamide riboside and/or nicotinamide mononucleotide using a genetically modified fungus.
Claims14
A genetically modified fungal strain capable of converting nicotinic acid mononucleotide (NaMN) to nicotinamide mononucleotide (NMN), wherein said strain comprising nicotinic acid mononucleotide amidating protein (NadE*) activity.
Dependencies are inferred from the claim text.